Explores greener solvent and resin combinations for solid-phase peptide synthesis, suggesting broader options for sustainable practices.
Until now, efforts to 'green' solid-phase peptide synthesis (SPPS) have largely focused on identifying a single solvent capable of replacing dimethylformamide, while relying exclusively on polystyrene-based resins. This approach has proven both challenging and limiting. Here, we propose that the most effective strategy for incorporating greener solvents into SPPS is to identify resin solvent combinations that can simultaneously support the two key reactions in peptide synthesis: coupling and Fmoc deprotection. When a relatively rigid resin is used, resin swelling is no longer a critical parameter in SPPS. This, in turn, enables the use of solvents that do not need to swell the resin, greatly expanding the range of greener solvent options that can be considered. This concept is exemplified by a novel polyacrylate-based rigid macroporous resin, which has enabled the SPPS synthesis of small- to medium-sized peptides using EtOAc, TEP, 2-MeTHF, acetone, and MeCN as single solvents.
No takes yet. Share an insight, caveat, or question.
Noki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: